Dynex Capital Increases Share Availability Amid Market Weakness
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 27 2026
0mins
Should l Buy DX?
Source: seekingalpha
Dynex Capital's stock fell by 5.01% as it crossed below the 5-day SMA, reflecting broader market weakness with the Nasdaq-100 down 1.46% and S&P 500 down 0.64%.
The company announced an amendment to its distribution agreement, increasing the number of shares available for sale by 60 million to a total of 221.29 million shares. This move is aimed at enhancing market liquidity and providing more options for future financing. Despite a decline in Q4 earnings due to rising expenses, Dynex reported increases in book value and net interest income, indicating a degree of financial health amidst challenges.
This increase in share availability may help Dynex navigate its funding needs more effectively, but the current market conditions could pose challenges for its stock performance in the near term.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DX
Wall Street analysts forecast DX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DX is 15.25 USD with a low forecast of 14.50 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 14.010
Low
14.50
Averages
15.25
High
16.00
Current: 14.010
Low
14.50
Averages
15.25
High
16.00
About DX
Dynex Capital, Inc. is a financial services company. The Company is an internally managed mortgage real estate investment trust (REIT), which invests in mortgage-backed securities (MBS). It finances its investments principally with repurchase agreements. Its objective is to provide attractive risk-adjusted returns to its shareholders over the long term that are reflective of a leveraged, high-quality fixed income portfolio with a focus on capital preservation. It seeks to provide returns to its shareholders primarily through the payment of regular dividends and through capital appreciation of its investments. It primarily invests in Agency MBS, of which over 97% are residential MBS (Agency RMBS), including to-be-announced (TBA) securities. The remainder of its investment portfolio consists of Agency commercial MBS (Agency CMBS) and Agency and non-Agency CMBS interest-only (CMBS IO) securities.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Dynex Capital Increases Share Availability by 60M
- Increased Share Availability: Dynex Capital announced an amendment to its distribution agreement, increasing the number of shares available for sale by 60 million to a total of 221.29 million shares, enhancing market liquidity and providing more options for future financing.
- Remaining Issuable Shares: The company has 67.35 million shares still available for issuance, which supports its flexible operations in the capital markets and helps address future funding needs.
- Enhanced Shareholder Returns: While raising $1.5 billion in capital, Dynex signals a shift to a tighter spread regime, expected to yield a 29.4% return for shareholders, thereby boosting investor confidence.
- Financial Performance Fluctuations: Despite a decline in Q4 earnings due to rising expenses, the company reported increases in book value and net interest income, indicating a degree of financial health amidst challenges.
See More
Wall Street Analysts Adjust Ratings
- Acumen Price Target Raised: BTIG raised Acumen Pharmaceuticals' price target from $4 to $7, with analyst Thomas Shrader maintaining a Buy rating, indicating confidence in the company's growth potential despite a closing price of $2.08 on Monday.
- Exelixis Target Price Increase: HC Wainwright & Co. raised the price target for Exelixis from $49 to $52, with analyst Robert Burns maintaining a Buy rating, reflecting optimism about its market performance, closing at $43.61 on Monday.
- Baker Hughes Price Target Upgraded: BMO Capital increased Baker Hughes' price target from $55 to $65, with analyst Phillip Jungwirth maintaining an Outperform rating, suggesting a positive outlook on its future performance, closing at $56.29 on Monday.
- Brown & Brown Price Target Cut: B of A Securities lowered the price target for Brown & Brown from $94 to $90, with analyst Joshua Shanker maintaining a Neutral rating, indicating a cautious stance on the company's short-term performance, closing at $79.62 on Monday.
See More
Dynex Capital Achieves 29.4% Total Shareholder Return in 2025
- Significant Shareholder Return: Dynex Capital achieved a total shareholder return of 29.4% in 2025, driven by both dividend income and substantial share price performance, which bolstered investor confidence and enhanced market positioning.
- Asset Scale Expansion: The company's total equity market capitalization nearly tripled to $3 billion, enhancing financial resilience and strategic flexibility, thereby providing stronger support for future investments.
- Strong Liquidity Position: As of Q4 2025, Dynex Capital held $1.4 billion in cash and unencumbered securities, representing over 55% of total equity, ensuring stability in uncertain market conditions.
- Record Economic Return: The company's total economic return reached 21.7% in 2025, marking the highest level in a decade, reflecting effective capital deployment strategies and market adaptability.
See More
Dynex Capital Reports 29.4% Shareholder Return and Triples Market Cap in 2025
- Significant Shareholder Returns: Dynex Capital achieved a 29.4% total shareholder return in 2025, alongside notable share price performance and dividend income, demonstrating the company's successful capital management strategy.
- Market Capitalization Growth: The company's total equity market capitalization nearly tripled to $3 billion within 13 months, reflecting effective execution in capital raising and investment, thereby enhancing market confidence.
- Management Changes: Dynex appointed Meakin Bennett as Chief Operating Officer and expanded its legal and investment teams, aiming to improve operational efficiency and strategic focus to support future growth.
- Strong Financial Performance: The total economic return for Q4 was 10.2%, with comprehensive income reaching $190 million, showcasing the company's adaptability and profitability amid changing market conditions.
See More
Dynex Capital (DX) Q4 2025 Earnings Transcript
See More
Dynex Capital Q4 Earnings Miss Expectations Amid Rising Expenses
- Earnings Miss: Dynex Capital reported Q4 earnings per share available for distribution at $0.22, falling short of the $0.27 analyst estimate and down from $0.25 in Q3, indicating profitability pressure amid rising costs.
- Balance Sheet Improvement: Despite the earnings decline, Dynex's book value per share increased from $12.67 on September 30 to $13.45 on December 31, reflecting positive progress in capital management.
- Economic Net Interest Income Growth: The economic net interest income rose to $51.1 million in Q4 from $44.9 million in Q3, demonstrating stability in interest income, although the interest spread slightly narrowed to 0.99%.
- Executive Changes and Capital Raising: Dynex raised $393 million in equity capital through at-the-market stock issuances, bringing total capital raised in 2025 to $1.2 billion, while appointing Rob Colligan as the new CFO and Meakin Bennett as COO to strengthen leadership and market competitiveness.
See More
Dynex Capital Increases Share Availability by 60M
- Increased Share Availability: Dynex Capital announced an amendment to its distribution agreement, increasing the number of shares available for sale by 60 million to a total of 221.29 million shares, enhancing market liquidity and providing more options for future financing.
- Remaining Issuable Shares: The company has 67.35 million shares still available for issuance, which supports its flexible operations in the capital markets and helps address future funding needs.
- Enhanced Shareholder Returns: While raising $1.5 billion in capital, Dynex signals a shift to a tighter spread regime, expected to yield a 29.4% return for shareholders, thereby boosting investor confidence.
- Financial Performance Fluctuations: Despite a decline in Q4 earnings due to rising expenses, the company reported increases in book value and net interest income, indicating a degree of financial health amidst challenges.
See More
Wall Street Analysts Adjust Ratings
- Acumen Price Target Raised: BTIG raised Acumen Pharmaceuticals' price target from $4 to $7, with analyst Thomas Shrader maintaining a Buy rating, indicating confidence in the company's growth potential despite a closing price of $2.08 on Monday.
- Exelixis Target Price Increase: HC Wainwright & Co. raised the price target for Exelixis from $49 to $52, with analyst Robert Burns maintaining a Buy rating, reflecting optimism about its market performance, closing at $43.61 on Monday.
- Baker Hughes Price Target Upgraded: BMO Capital increased Baker Hughes' price target from $55 to $65, with analyst Phillip Jungwirth maintaining an Outperform rating, suggesting a positive outlook on its future performance, closing at $56.29 on Monday.
- Brown & Brown Price Target Cut: B of A Securities lowered the price target for Brown & Brown from $94 to $90, with analyst Joshua Shanker maintaining a Neutral rating, indicating a cautious stance on the company's short-term performance, closing at $79.62 on Monday.
See More
Dynex Capital Achieves 29.4% Total Shareholder Return in 2025
- Significant Shareholder Return: Dynex Capital achieved a total shareholder return of 29.4% in 2025, driven by both dividend income and substantial share price performance, which bolstered investor confidence and enhanced market positioning.
- Asset Scale Expansion: The company's total equity market capitalization nearly tripled to $3 billion, enhancing financial resilience and strategic flexibility, thereby providing stronger support for future investments.
- Strong Liquidity Position: As of Q4 2025, Dynex Capital held $1.4 billion in cash and unencumbered securities, representing over 55% of total equity, ensuring stability in uncertain market conditions.
- Record Economic Return: The company's total economic return reached 21.7% in 2025, marking the highest level in a decade, reflecting effective capital deployment strategies and market adaptability.
See More
Dynex Capital Reports 29.4% Shareholder Return and Triples Market Cap in 2025
- Significant Shareholder Returns: Dynex Capital achieved a 29.4% total shareholder return in 2025, alongside notable share price performance and dividend income, demonstrating the company's successful capital management strategy.
- Market Capitalization Growth: The company's total equity market capitalization nearly tripled to $3 billion within 13 months, reflecting effective execution in capital raising and investment, thereby enhancing market confidence.
- Management Changes: Dynex appointed Meakin Bennett as Chief Operating Officer and expanded its legal and investment teams, aiming to improve operational efficiency and strategic focus to support future growth.
- Strong Financial Performance: The total economic return for Q4 was 10.2%, with comprehensive income reaching $190 million, showcasing the company's adaptability and profitability amid changing market conditions.
See More
Dynex Capital (DX) Q4 2025 Earnings Transcript
See More
Dynex Capital Q4 Earnings Miss Expectations Amid Rising Expenses
- Earnings Miss: Dynex Capital reported Q4 earnings per share available for distribution at $0.22, falling short of the $0.27 analyst estimate and down from $0.25 in Q3, indicating profitability pressure amid rising costs.
- Balance Sheet Improvement: Despite the earnings decline, Dynex's book value per share increased from $12.67 on September 30 to $13.45 on December 31, reflecting positive progress in capital management.
- Economic Net Interest Income Growth: The economic net interest income rose to $51.1 million in Q4 from $44.9 million in Q3, demonstrating stability in interest income, although the interest spread slightly narrowed to 0.99%.
- Executive Changes and Capital Raising: Dynex raised $393 million in equity capital through at-the-market stock issuances, bringing total capital raised in 2025 to $1.2 billion, while appointing Rob Colligan as the new CFO and Meakin Bennett as COO to strengthen leadership and market competitiveness.
See More
